Submission conditions

A. General Conditions

  1. Abstracts are required for all oral presentations, e-posters and paper posters
  2. Abstracts must be submitted by 21 September 2021, 23:59 CEST.                                                                                
  3. Max. 6 abstracts with the same presenting author can be submitted
  4. Abstracts must be submitted in English or French. Please note that they are submitted in 2 different systems depending on the language.
  5. Accepted abstracts will be published on the conference website, in the Conference App and in              EWMA Conference Knowledge. By submitting an abstract you consent to giving EWMA permission to publish your abstract.
  6. Withdrawal of abstracts can only be accepted if notified in writing and subsequently confirmed by the              EWMA Secretariat. It is only possible to withdraw an abstract until 14 days after notification on                            acceptance.

B. Presenting Author and Registration

  1. The presenting author must register as a participant for the full conference at the latest 14 days after                 acceptance of an abstract
  2. Failure to register shall not be regarded as an automatic withdrawal of your abstract. Withdrawal of an            abstract can only be made by writing to the Secretariat - see item A.6 above
  3. EWMA reserves the right to exclude any abstract from the scientific programme that is not followed by a           participant registration 1 January 2022 at the latest.
  4. Please note that max. 2 oral presentations and max. 2 poster presentations by the same presenting                   author will be accepted for presentation at the conference. NB! The presenting author does not have to           be the 1st author.


C. Contents of your abstract

  1. The abstract word limit is max. 250 words per abstract excl. title, authors and affiliations. The EWMA                   Secretariat reserves the right to edit abstracts that exceed the word limit
  2. The title should be as brief as possible but long enough to clearly indicate the nature of the study.                       Write the abstract title in CAPITAL LETTERS. No full stop at the end
  3. No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be                   listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the             name(s) of author(s) and their institution(s), when you submit your abstract online
  4. The abstract must include the following:
           Aim: Clearly state the purpose of the abstract.
           Methods: Describe your selection of observations or experimental subjects clearly.
           Results: Present your results in a logical sequence in text, table and illustrations.
           Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and           the conclusions that are drawn from them
  5. All abbreviations must be defined in first use. Statements such as “results will be discussed” or “data                   will be presented” cannot be accepted.
  6. Use of brand names: For all references to products or companies, generic names must be used. The                 brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand           names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be                 rejected for this reason only. EWMA reserves the right to replace any brand name with a generic name             without further notice
  7. Abstracts will not be accepted if previously presented at a EWMA conference unless there is a substantial         increase in data.

D. Reviewing

  1. The Scientific Committee will review the abstract
  2. Notification of acceptance or rejection of the abstract will be sent to the submitter by April 2021.
  3. It is the responsibility of all submitters that all studies are performed with respect to national legislation,           international legislation and ethical guidelines both with regards to humans and animals. The Scientific             Committee reserves the right to reject any submitted abstract that is believed to violate these principles.
  4. Please verify that your email address (submitter and presenting author) is correct as it will be used for              contacting you after the review process

For all enquiries regarding abstracts and speakers, please contact the EWMA Secretariat at